Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001458 · ClinicalTrials.gov registry record
Evaluation of Patients With Heart Disease Not Eligible for Research Protocols
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 7,829
- Enrollment target
NCT00001458: Completed study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00001458 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 7,829 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001458 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 7,829 participants
- Enrollment target
Study Summary
An important mission of the National Institutes of Health (NIH) is to develop and carry out research studies designed to improve understanding of disease processes and treatments. Clinical research continues to become more focused on specific diseases and the signs and symptoms of diseases in specific groups of people and patients. This study is designed to permit inpatient evaluation and care of patients with heart disease who do not qualify to participate in research studies being conducted by the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). These patients are valuable to the Cardiology Branch of the NHLBI because they help to improve training and experience of its researchers.
Primary Outcome
staff becomes familiar or proficient in cardiovascular diagnostic studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,829 participants |
| Start Date | 1995-01-01 |
| Est. Completion | 2020-07-28 |
What the finished NCT00001458 record still lists
NCT00001458 is an observational study that tracks outcomes without assigning an intervention. Its 7,829 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001458 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001458 about?
NCT00001458 is a clinical study titled "Evaluation of Patients With Heart Disease Not Eligible for Research Protocols". An important mission of the National Institutes of Health (NIH) is to develop and carry out research studies designed to improve understanding of disease processes and treatments. Clinical research continues to become more focused on specific diseases and the signs and symptoms of diseases in speci...
What is the current status of trial NCT00001458?
This trial is currently completed. The enrollment target is 7,829 participants. The study started on 1995-01-01. Estimated completion is 2020-07-28.
Who is sponsoring clinical trial NCT00001458?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI